Dynavax Technologies
DVAX
£8.38
Share price
-0.89%
Change (1 day)
-7.03%
Change (1 year)
Categories
Dynavax Technologies (DVAX) Fails to deliver data
Key failure to deliver metrics for Dynavax Technologies :
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: £0.04 M
- Last 3 months FTD volume: £0.18 M
- Last year FTD volume: £0.18 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Dynavax Technologies (DVAX) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Dynavax Technologies (DVAX) - since 2014
Volume in USD (price x number of shares), data since 2014Dynavax Technologies (DVAX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | £0.72 M | -97.77% |
| 2024 | £32.36 M | 242.11% |
| 2023 | £9.46 M | -85.84% |
| 2022 | £66.82 M | 108.46% |
| 2021 | £32.05 M | -17.88% |
| 2020 | £39.03 M | 10.44% |
| 2019 | £35.34 M | 148.8% |
| 2018 | £14.2 M | -54.86% |
| 2017 | £31.46 M | 4.28% |
| 2016 | £30.17 M | 37.8% |
| 2015 | £21.9 M | 108.04% |
| 2014 | £10.52 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Agenus
AGEN | £2.3 M | £5.81 M | 🇺🇸 USA |
 Biogen BIIB | £8.78 M | £62.76 M | 🇺🇸 USA |
 Merck MRK | £12.12 M | £0.17 B | 🇺🇸 USA |
 Gilead Sciences GILD | £16.11 M | £0.25 B | 🇺🇸 USA |
 AstraZeneca AZN | £23.77 M | £0.14 B | 🇬🇧 UK |
 GlaxoSmithKline GSK | £0.11 B | £0.38 B | 🇬🇧 UK |
 Pfizer PFE | £26.37 M | £0.27 B | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | £8.83 M | £41.28 M | 🇮🇱 Israel |
 Amgen AMGN | £21.56 M | £0.29 B | 🇺🇸 USA |